NCT02283515View on ClinicalTrials.gov

Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Chronic Periodontitis
Interventions
DRUG

Rosuvastatin

Rosuvastatin (RSV) is one of new synthetic, second-generation, sulfur-containing, hydrophilic statin, a highly efficient competitive inhibitors of HMG CoA Reductase having important role in reducing serum cholesterol concentrations and lowers the risk of cardiovascular disease.

All Listed Sponsors
lead

Government Dental College and Research Institute, Bangalore

OTHER

NCT02283515 - Efficacy of Locally Delivred 1.2% Rosuvastatin Gel in Chronic Periodontitis | Biotech Hunter | Biotech Hunter